751
Views
8
CrossRef citations to date
0
Altmetric
Research Paper

Immunogenicity and safety of three 2010–2011 seasonal trivalent influenza vaccines in Chinese toddlers, children and older adults

A double-blind and randomized trial

, , , , , , , , , & show all
Pages 1725-1734 | Received 05 Feb 2013, Accepted 23 Apr 2013, Published online: 04 Jun 2013

References

  • Bridges CB, Katz JM, Levandowski RA, Cox NJ. Inactivated influenza vaccines. In: Plotkin SA, Orenstein WA, Offit PA, eds. Vaccines. Amsterdam: Elsevier Inc, 2008:259-90.
  • Fiore AE, Shay DK, Haber P, Iskander JK, Uyeki TM, Mootrey G, et al, Advisory Committee on Immunization Practices (ACIP), Centers for Disease Control and Prevention (CDC). Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2007. MMWR Recomm Rep 2007; 56:RR-6 1 - 54; PMID: 17625497
  • World Health Organization. WHO position paper on influenza vaccines. Wkly Epidemiol Rec 2005; 33:279 - 87
  • World Health Organization. DG Statement following the meeting of the Emergency Committee. http://www.who.int/csr/disease/swineflu/4th_meeting_ihr/en/index.html (accessed September 18, 2012)
  • Wu J, Xu F, Lu L, Lu M, Miao L, Gao T, et al. Safety and effectiveness of a 2009 H1N1 vaccine in Beijing. N Engl J Med 2010; 363:2416 - 23; http://dx.doi.org/10.1056/NEJMoa1006736; PMID: 21158658
  • World Health Organization. H1N1 in post-pandemic period. http://www.who.int/mediacentre/news/statements/2010/h1n1_vpc_20100810/en/index.html (accessed September 18, 2012)
  • World Health Organization. Recommended viruses for influenza vaccines for use in the 2010-2011 northern hemisphere influenza season. Wkly Epidemiol Rec 2010; 85:81 - 92; PMID: 20210260
  • Liang XF, Wang HQ, Wang JZ, Fang HH, Wu J, Zhu FC, et al. Safety and immunogenicity of 2009 pandemic influenza A H1N1 vaccines in China: a multicentre, double-blind, randomised, placebo-controlled trial. Lancet 2010; 375:56 - 66; http://dx.doi.org/10.1016/S0140-6736(09)62003-1; PMID: 20018364
  • Zhu FC, Wang H, Fang HH, Yang JG, Lin XJ, Liang XF, et al. A novel influenza A (H1N1) vaccine in various age groups. N Engl J Med 2009; 361:2414 - 23; http://dx.doi.org/10.1056/NEJMoa0908535; PMID: 19846844
  • Garten RJ, Davis CT, Russell CA, Shu B, Lindstrom S, Balish A, et al. Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science 2009; 325:197 - 201; http://dx.doi.org/10.1126/science.1176225; PMID: 19465683
  • Langley JM, Scheifele DW, Quach C, Vanderkooi OG, Ward B, McNeil S, et al. Safety and immunogenicity of 2010-2011 H1N12009-containing trivalent inactivated influenza vaccine in children 12-59 months of age previously given AS03-adjuvanted H1N12009 pandemic vaccine: a PHAC/CIHR Influenza Research Network (PCIRN) study. Vaccine 2012; 30:3389 - 94; http://dx.doi.org/10.1016/j.vaccine.2012.03.046; PMID: 22469860
  • Loebermann M, Anders G, Brestrich G, Fritzsche C, Klammt S, Boršo D, et al. Safety and immunogenicity of a trivalent single dose seasonal influenza vaccine containing pandemic A(H1N1) antigen in younger and elderly subjects: a phase III open-label single-arm study. Vaccine 2011; 29:1228 - 34; http://dx.doi.org/10.1016/j.vaccine.2010.11.092; PMID: 21167116
  • Tregnaghi MW, Stamboulian D, Vanadía PC, Tregnaghi JP, Calvari M, Fragapane E, et al. Immunogenicity, safety, and tolerability of two trivalent subunit inactivated influenza vaccines: a phase III, observer-blind, randomized, controlled multicenter study. Viral Immunol 2012; 25:216 - 25; PMID: 22691101
  • Künzel W, Engelmann H, D’Hondt E. Immune response to influenza vaccination. Lancet 1994; 343:173; http://dx.doi.org/10.1016/S0140-6736(94)90962-8; PMID: 7904017
  • Künzel W, Glathe H, Engelmann H, Van Hoecke C. Kinetics of humoral antibody response to trivalent inactivated split influenza vaccine in subjects previously vaccinated or vaccinated for the first time. Vaccine 1996; 14:1108 - 10; http://dx.doi.org/10.1016/0264-410X(96)00061-8; PMID: 8911005
  • Cox RJ, Brokstad KA, Zuckerman MA, Wood JM, Haaheim LR, Oxford JS. An early humoral immune response in peripheral blood following parenteral inactivated influenza vaccination. Vaccine 1994; 12:993 - 9; http://dx.doi.org/10.1016/0264-410X(94)90334-4; PMID: 7975853
  • European Committee for Proprietary Medicinal Products. Note for guidance on harmonisation of requirements for influenza vaccines (CPMP/BWP/214/96). European Agency for the Evaluation of Medicinal Products, 1997.
  • Division of Microbiology and Infectious Diseases. DMID pediatric toxicity tables. http://www.niaid.nih.gov/LabsAndResources/resources/DMIDClinRsrch/Documents/dmidpedtox.pdf (accessed September 19, 2012)
  • Division of Microbiology and Infectious Diseases. DMID adult toxicity tables. http://www.niaid.nih.gov/LabsAndResources/resources/DMIDClinRsrch/Documents/dmidadulttox.pdf (accessed September 19, 2012)
  • World Health Organization. WHO manual on animal influenza diagnosis and surveillance. Geneva: The World Health Organization 2002.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.